 | • レポートコード：D0GIR-01202 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃がん・胃がん治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃がん・胃がん治療の種類別市場規模（プログラム細胞死タンパク質1（PD-1）阻害剤、ヒト上皮成長因子受容体（HER2）拮抗薬、血管内皮増殖因子受容体（VEGFR）拮抗薬、その他）、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Ipsen Pharma、Celltrion Inc.、Eli Lilly、Merck & Co., Inc.、Bayer AG、Bristol-Myers Squibb Company、Jiangsu Hengrui Medicine Co., Ltd.、Novartis AG、Roche、TAIHO PHARMACEUTICAL CO., LTD. ・地域別グローバル市場分析 2015年-2020年 ・胃がん・胃がん治療の北米市場（アメリカ、カナダ、メキシコ） ・胃がん・胃がん治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃がん・胃がん治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃がん・胃がん治療の南米市場（ブラジル、アルゼンチン） ・胃がん・胃がん治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プログラム細胞死タンパク質1（PD-1）阻害剤、ヒト上皮成長因子受容体（HER2）拮抗薬、血管内皮増殖因子受容体（VEGFR）拮抗薬、その他 ・用途別分析：病院、クリニック ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Stomach Cancer and Gastric Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Stomach Cancer and Gastric Cancer Treatment sales will be xx in 2020 from Stomach Cancer and Gastric Cancer Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Stomach Cancer and Gastric Cancer Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Stomach Cancer and Gastric Cancer Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Stomach Cancer and Gastric Cancer Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Stomach Cancer and Gastric Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Stomach Cancer and Gastric Cancer Treatment market has been segmented into:
Programmed Cell Death Protein 1 (PD-1) Inhibitors
Human Epidermal Growth Factor Receptor (HER2) Antagonists
Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
Others
By Application, Stomach Cancer and Gastric Cancer Treatment has been segmented into:
Hospitals
Clinics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Stomach Cancer and Gastric Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Stomach Cancer and Gastric Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Stomach Cancer and Gastric Cancer Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Stomach Cancer and Gastric Cancer Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Stomach Cancer and Gastric Cancer Treatment Market Share Analysis
Stomach Cancer and Gastric Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Stomach Cancer and Gastric Cancer Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Stomach Cancer and Gastric Cancer Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Stomach Cancer and Gastric Cancer Treatment are:
Ipsen Pharma
Celltrion Inc.
Eli Lilly
Merck & Co., Inc.
Bayer AG
Bristol-Myers Squibb Company
Jiangsu Hengrui Medicine Co., Ltd.
Novartis AG
Roche
TAIHO PHARMACEUTICAL CO., LTD.
Among other players domestic and global, Stomach Cancer and Gastric Cancer Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Stomach Cancer and Gastric Cancer Treatment Market Overview
1.1 Product Overview and Scope of Stomach Cancer and Gastric Cancer Treatment
1.2 Classification of Stomach Cancer and Gastric Cancer Treatment by Type
1.2.1 Global Stomach Cancer and Gastric Cancer Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Type in 2019
1.2.3 Programmed Cell Death Protein 1 (PD-1) Inhibitors
1.2.4 Human Epidermal Growth Factor Receptor (HER2) Antagonists
1.2.5 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists
1.2.6 Others
1.3 Global Stomach Cancer and Gastric Cancer Treatment Market by Application
1.3.1 Overview: Global Stomach Cancer and Gastric Cancer Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Stomach Cancer and Gastric Cancer Treatment Market by Regions
1.4.1 Global Stomach Cancer and Gastric Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Stomach Cancer and Gastric Cancer Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Stomach Cancer and Gastric Cancer Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Stomach Cancer and Gastric Cancer Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Stomach Cancer and Gastric Cancer Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Stomach Cancer and Gastric Cancer Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Stomach Cancer and Gastric Cancer Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Stomach Cancer and Gastric Cancer Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Stomach Cancer and Gastric Cancer Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Stomach Cancer and Gastric Cancer Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Ipsen Pharma
2.1.1 Ipsen Pharma Details
2.1.2 Ipsen Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Ipsen Pharma SWOT Analysis
2.1.4 Ipsen Pharma Product and Services
2.1.5 Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celltrion Inc.
2.2.1 Celltrion Inc. Details
2.2.2 Celltrion Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celltrion Inc. SWOT Analysis
2.2.4 Celltrion Inc. Product and Services
2.2.5 Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck & Co., Inc. SWOT Analysis
2.4.4 Merck & Co., Inc. Product and Services
2.4.5 Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bayer AG SWOT Analysis
2.5.4 Bayer AG Product and Services
2.5.5 Bayer AG Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers Squibb Company SWOT Analysis
2.6.4 Bristol-Myers Squibb Company Product and Services
2.6.5 Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Jiangsu Hengrui Medicine Co., Ltd.
2.7.1 Jiangsu Hengrui Medicine Co., Ltd. Details
2.7.2 Jiangsu Hengrui Medicine Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Jiangsu Hengrui Medicine Co., Ltd. SWOT Analysis
2.7.4 Jiangsu Hengrui Medicine Co., Ltd. Product and Services
2.7.5 Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis AG SWOT Analysis
2.8.4 Novartis AG Product and Services
2.8.5 Novartis AG Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 TAIHO PHARMACEUTICAL CO., LTD.
2.10.1 TAIHO PHARMACEUTICAL CO., LTD. Details
2.10.2 TAIHO PHARMACEUTICAL CO., LTD. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 TAIHO PHARMACEUTICAL CO., LTD. SWOT Analysis
2.10.4 TAIHO PHARMACEUTICAL CO., LTD. Product and Services
2.10.5 TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Stomach Cancer and Gastric Cancer Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Stomach Cancer and Gastric Cancer Treatment Players Market Share
3.2.2 Top 10 Stomach Cancer and Gastric Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Stomach Cancer and Gastric Cancer Treatment Revenue and Market Share by Regions
4.2 North America Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
5 North America Stomach Cancer and Gastric Cancer Treatment Revenue by Countries
5.1 North America Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
5.2 USA Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
6 Europe Stomach Cancer and Gastric Cancer Treatment Revenue by Countries
6.1 Europe Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
6.2 Germany Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
6.4 France Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
7.2 China Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
7.5 India Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
8 South America Stomach Cancer and Gastric Cancer Treatment Revenue by Countries
8.1 South America Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
8.2 Brazil Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Stomach Cancer and Gastric Cancer Treatment by Countries
9.1 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Stomach Cancer and Gastric Cancer Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Stomach Cancer and Gastric Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Programmed Cell Death Protein 1 (PD-1) Inhibitors Revenue Growth Rate (2015-2025)
10.4 Human Epidermal Growth Factor Receptor (HER2) Antagonists Revenue Growth Rate (2015-2025)
10.5 Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Stomach Cancer and Gastric Cancer Treatment Market Segment by Application
11.1 Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Application (2015-2020)
11.2 Stomach Cancer and Gastric Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
12 Global Stomach Cancer and Gastric Cancer Treatment Market Size Forecast (2021-2025)
12.1 Global Stomach Cancer and Gastric Cancer Treatment Market Size Forecast (2021-2025)
12.2 Global Stomach Cancer and Gastric Cancer Treatment Market Forecast by Regions (2021-2025)
12.3 North America Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
12.6 South America Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Stomach Cancer and Gastric Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Stomach Cancer and Gastric Cancer Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Ipsen Pharma Corporate Information, Location and Competitors
Table 7. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Major Business
Table 8. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Ipsen Pharma SWOT Analysis
Table 10. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 11. Ipsen Pharma Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Celltrion Inc. Corporate Information, Location and Competitors
Table 13. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Major Business
Table 14. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Celltrion Inc. SWOT Analysis
Table 16. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 17. Celltrion Inc. Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Eli Lilly Corporate Information, Location and Competitors
Table 19. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Major Business
Table 20. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Eli Lilly SWOT Analysis
Table 22. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 23. Eli Lilly Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 25. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Major Business
Table 26. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Merck & Co., Inc. SWOT Analysis
Table 28. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 29. Merck & Co., Inc. Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Bayer AG Corporate Information, Location and Competitors
Table 31. Bayer AG Stomach Cancer and Gastric Cancer Treatment Major Business
Table 32. Bayer AG Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Bayer AG SWOT Analysis
Table 34. Bayer AG Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 35. Bayer AG Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 37. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Major Business
Table 38. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Bristol-Myers Squibb Company SWOT Analysis
Table 40. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 41. Bristol-Myers Squibb Company Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Jiangsu Hengrui Medicine Co., Ltd. Corporate Information, Location and Competitors
Table 43. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Major Business
Table 44. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Jiangsu Hengrui Medicine Co., Ltd. SWOT Analysis
Table 46. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 47. Jiangsu Hengrui Medicine Co., Ltd. Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Novartis AG Corporate Information, Location and Competitors
Table 49. Novartis AG Stomach Cancer and Gastric Cancer Treatment Major Business
Table 50. Novartis AG Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Novartis AG SWOT Analysis
Table 52. Novartis AG Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 53. Novartis AG Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Roche Corporate Information, Location and Competitors
Table 55. Roche Stomach Cancer and Gastric Cancer Treatment Major Business
Table 56. Roche Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Roche SWOT Analysis
Table 58. Roche Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 59. Roche Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. TAIHO PHARMACEUTICAL CO., LTD. Corporate Information, Location and Competitors
Table 61. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Major Business
Table 62. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 63. TAIHO PHARMACEUTICAL CO., LTD. SWOT Analysis
Table 64. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Product and Solutions
Table 65. TAIHO PHARMACEUTICAL CO., LTD. Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) by Players (2015-2020)
Table 67. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Players (2015-2020)
Table 68. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Regions (2015-2020)
Table 70. North America Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
Table 71. North America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 72. Europe Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Stomach Cancer and Gastric Cancer Treatment Revenue by Countries (2015-2020)
Table 75. South America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 78. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) by Type (2015-2020)
Table 79. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Type (2015-2020)
Table 80. Global Stomach Cancer and Gastric Cancer Treatment Revenue Forecast by Type (2021-2025)
Table 81. Global Stomach Cancer and Gastric Cancer Treatment Revenue by Application (2015-2020)
Table 82. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Application (2015-2020)
Table 83. Global Stomach Cancer and Gastric Cancer Treatment Revenue Forecast by Application (2021-2025)
Table 84. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Stomach Cancer and Gastric Cancer Treatment Picture
Figure 2. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Type in 2019
Figure 3. Programmed Cell Death Protein 1 (PD-1) Inhibitors Picture
Figure 4. Human Epidermal Growth Factor Receptor (HER2) Antagonists Picture
Figure 5. Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Picture
Figure 6. Others Picture
Figure 7. Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Global Stomach Cancer and Gastric Cancer Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Stomach Cancer and Gastric Cancer Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Stomach Cancer and Gastric Cancer Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries in 2019
Figure 43. China Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Stomach Cancer and Gastric Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Type in 2019
Figure 60. Global Stomach Cancer and Gastric Cancer Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Programmed Cell Death Protein 1 (PD-1) Inhibitors Revenue Growth Rate (2015-2020)
Figure 62. Global Human Epidermal Growth Factor Receptor (HER2) Antagonists Revenue Growth Rate (2015-2020)
Figure 63. Global Vascular Endothelial Growth Factor Receptor (VEGFR) Antagonists Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Application (2015-2020)
Figure 66. Global Stomach Cancer and Gastric Cancer Treatment Revenue Share by Application in 2019
Figure 67. Global Stomach Cancer and Gastric Cancer Treatment Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Stomach Cancer and Gastric Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Stomach Cancer and Gastric Cancer Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Stomach Cancer and Gastric Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
胃がん・胃がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Stomach Cancer and Gastric Cancer Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…- 基底細胞皮膚癌治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Basal Cell Skin Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 非血液がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Hematological Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Hemato…
- 前立腺がん治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prostate Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostate Canc…
- 大腸がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Colorectal Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…